Test by Body Systems

The Heart Health - Basic Panel is a crucial set of tests tailored to evaluate key factors that influence cardiovascular health. This panel is designed to offer a snapshot of an individual's risk for heart disease by assessing lipid profiles, inflammatory markers, and proteins associated with heart health. It serves as an essential tool for early detection of potential heart issues, guiding preventive measures, and monitoring the effectiveness of lifestyle changes or treatments aimed at improving heart health.

The Heart Health - Basic Plus Panel is an enhanced diagnostic tool designed for a more comprehensive assessment of cardiovascular health risks. This panel integrates crucial markers for heart health, including lipid profiles, proteins associated with cardiovascular diseases, and markers of inflammation and metabolic health. It provides a nuanced picture of an individual's heart health, helping to identify risks earlier and more accurately than basic screenings.

The Heart Health - Advanced Panel is a comprehensive suite of tests aimed at evaluating a wide range of factors that contribute to cardiovascular health. This panel is designed to offer an in-depth look into the biomarkers associated with heart disease risk, including lipid profiles, inflammatory markers, blood glucose levels, and more. It serves as a critical tool for identifying potential heart health issues, guiding interventions to mitigate risk, and monitoring the effectiveness of lifestyle changes or treatments aimed at improving cardiovascular outcomes.

The Heart Health - Comprehensive Panel provides an extensive array of tests designed to thoroughly assess various aspects of heart health. This panel combines markers of cholesterol management, inflammation, clotting factors, blood sugar levels, kidney function, and more to offer a holistic view of an individual's cardiovascular risk profile. It is particularly beneficial for individuals with a high risk of heart disease, those with existing heart conditions, or anyone interested in a detailed analysis of their heart health.

The Activated Partial Thromboplastin Time (aPTT) Test measures how long it takes blood to clot, evaluating clotting factors and overall coagulation function. Abnormal results may indicate bleeding disorders, hemophilia, liver disease, or clotting factor deficiencies. Doctors also use this test to monitor patients on heparin therapy. Results provide essential insight into blood clotting, bleeding risk, and treatment management for safe medical care.

Also Known As: aPTT Test, PTT Test

The Activated Protein C-Resistance Test evaluates how blood responds to activated protein C, helping identify resistance often caused by Factor V Leiden mutation. This test supports assessment of abnormal clotting, deep vein thrombosis, and inherited thrombophilia. By measuring clotting response, it provides insight into genetic risks, venous thromboembolism, and overall coagulation health.

The Albumin Random Urine Test with Creatinine measures albumin and creatinine levels in a urine sample to evaluate kidney health. Elevated albumin (microalbuminuria) may indicate early kidney disease, diabetes complications, or hypertension-related damage. Doctors use this test to detect kidney problems before symptoms appear, monitor chronic conditions, and guide treatment. It provides vital insight into renal function and long-term kidney disease management.

Also Known As: Urine Albumin Test, Random Microalbumin Test, uACR Test

The ANA Screen IFA with Reflex to Titer and Pattern Test detects antinuclear antibodies in blood to evaluate autoimmune activity. If positive, further testing identifies antibody concentration (titer) and fluorescence pattern, helping diagnose conditions like lupus, rheumatoid arthritis, or Sjögren’s syndrome. Doctors order this test to investigate symptoms such as joint pain, fatigue, rash, or swelling and to guide treatment for autoimmune and connective tissue disorders.

Also Known As: ANA Test, Antinuclear Antibody Screen Test

The Antithrombin III Activity Test evaluates how effectively antithrombin controls clot formation in the blood. Reduced activity may indicate a hereditary deficiency, abnormal coagulation, or increased risk for venous thrombosis. This test provides insight into clotting disorders, supports diagnosis of thrombophilia, and helps assess vascular health and systemic risks related to impaired anticoagulant activity.

The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.

Also Known As: Apo A1 and B Test, Apolipoprotein Evaluation Test

The Basic Metabolic Panel (BMP) Test measures eight markers, including glucose, calcium, sodium, potassium, chloride, carbon dioxide, BUN, and creatinine, to evaluate kidney function, blood sugar, and electrolyte balance. Doctors use this panel to detect diabetes, dehydration, and kidney disease, or to monitor treatment. It is commonly ordered in routine exams, emergency care, or pre-surgical testing to assess overall metabolic and organ health.

Also Known As: BMP Test, Chemistry Panel, Chemistry Screen, Chem 7, Chem 11, SMA 7, SMAC7, Basic Metabolic Test, Chem Test, Chem Panel Test 

The Blood Culture Test detects bacteria or fungi in the bloodstream to diagnose serious infections like sepsis, endocarditis, or systemic fungal infections. Doctors order this test when patients have fever, chills, or low blood pressure. Positive results identify the type of pathogen and guide targeted antibiotic or antifungal treatment. Early detection through blood culture is critical for effective care, preventing complications, and improving patient outcomes.

Also Known As: Blood Bacteria Test, Fungal Blood Test, Sepsis Test

The B-Type Natriuretic Peptide (BNP) Test measures BNP levels in blood to help diagnose and monitor heart failure and other cardiac conditions. High levels suggest the heart is under stress, often from congestive heart failure, hypertension, or heart disease. Doctors order this test for patients with shortness of breath, fatigue, or swelling. Results provide critical insight into heart function, guiding treatment and monitoring response to therapy.

Also Known As: Brain Natriuretic Peptide Test

The Cardio IQ™ ApoE Genotype Test analyzes apolipoprotein E (ApoE) gene variants linked to cholesterol metabolism and cardiovascular risk. Results help assess risk for heart disease, hyperlipidemia, and Alzheimer’s disease. This genetic test guides personalized prevention and treatment strategies, including diet, lifestyle, and lipid-lowering therapies, supporting long-term cardiovascular and brain health.

Also Known As: ApoE Cardiac Risk Test, ApoE Cardiovascular Disease Test, Apolipoprotein E Test, Apo E Test, ApoE Protein Test

The Cardio IQ™ Lipoprotein Fractionation Ion Mobility Test separates and measures lipoprotein particles by size and concentration using ion mobility technology. It provides a detailed profile of LDL, HDL, and other subclasses, offering a clearer assessment of cardiovascular risk than standard cholesterol testing.

Also Known As: LDL Particle Testing, LDL Subclass Test, LDL Fractionations Test

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

Also Known As: CBC Test, CBC with Differential and Platelets Test, CBC w/Diff and Platelets Test, Full Blood Count Test, Complete Blood Count Test

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Also Known As: CMP Test, Chemistry Panel Test, Chem Test, Chem 21 Test, Chem 14 Test 

The Creatine Kinase (CK) Isoenzymes with Total CK Panel measures overall CK levels and breaks them into isoenzymes (CK-MM, CK-MB, CK-BB) to identify muscle, heart, or brain injury. Elevated CK-MB may suggest a heart attack, while CK-MM points to skeletal muscle damage, and CK-BB indicates brain injury. Doctors order this test for chest pain, muscle weakness, or trauma. Results provide critical insight for diagnosing and monitoring tissue damage.

Also Known As: CPK Isoenzymes Test

The Creatine Kinase (CK) Total Test measures CK enzyme levels in blood to detect muscle injury, inflammation, or stress. Elevated CK may indicate muscle disorders, heart attack, strenuous exercise, or conditions such as rhabdomyolysis, while low levels are less common. Doctors use this test to evaluate unexplained muscle pain, weakness, or chest pain and to monitor recovery. It provides insight into muscle, cardiac, and overall metabolic health.

Also Known As: CK Total Test, Creatine Phosphokinase, CPK Test

The Cystatin C Test with eGFR measures blood levels of Cystatin C, a protein filtered by the kidneys, and calculates estimated glomerular filtration rate (eGFR). This test provides a sensitive marker for kidney function and can detect early kidney disease, even when creatinine levels are normal. Doctors order it to evaluate chronic kidney disease risk, monitor treatment, and assess overall kidney health in patients with diabetes, hypertension, or other conditions.

Also Known As: CysX Test, CysC Test

The Factor V Leiden Mutation Analysis detects a genetic mutation in the F5 gene that increases risk of abnormal blood clotting (thrombophilia). Individuals with this mutation may be prone to deep vein thrombosis (DVT), pulmonary embolism, or pregnancy complications. Doctors use this DNA test to confirm inherited clotting disorders, assess family risk, and guide prevention strategies, including anticoagulation or lifestyle management.

Also Known As: Factor 5 Test, Factor V Test